Exposure to Latent Tuberculosis Treatment during Pregnancy. The PREVENT TB and the iAdhere Trials. [electronic resource]
Producer: 20191028Description: 570-580 p. digitalISSN:- 2325-6621
- Adolescent
- Adult
- Antitubercular Agents -- administration & dosage
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Drug Therapy, Combination
- Female
- Humans
- Infant, Newborn
- Isoniazid -- administration & dosage
- Latent Tuberculosis -- drug therapy
- Middle Aged
- Pregnancy
- Pregnancy Complications, Infectious -- drug therapy
- Pregnancy Outcome
- Rifampin -- administration & dosage
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase III; Clinical Trial, Phase IV; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.